Chris Bulman Inc

Position in JNJ — Johnson & Johnson

CIK 2032404 ROSEVILLE, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$343,621

+$41,005 QoQ

Shares Held

1,353

+9.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.66%

of 13F equity value

Holder Rank

#4,056

of 4,676 holders

Holding Since

Jun 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Chris Bulman Inc holds $1,680,788 across 5 Drug Manufacturers - General names. JNJ ranks #3 (20.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	2,003	$504,034
2	LLY	ELI LILLY & Co	294	$352,632
3	JNJ	Johnson & Johnson This page	1,353	$343,621
4	GILD	Gilead Sciences, Inc.	1,923	$242,951
5	AMGN	Amgen Inc	656	$237,550

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$343,621	1,353	+9.3%	Shares	Sole	2026-07-22
2026-03-31	$302,616	1,238	-7.1%	Shares	Sole	2026-04-13
2025-12-31	$275,864	1,333	-43.2%	Shares	Sole	2026-01-14
2025-03-31	$389,392	2,348	+5.6%	Shares	Sole	2025-04-15
2024-12-31	$321,634	2,224	+4.3%	Shares	Sole	2025-02-10
2024-09-30	$345,511	2,132	+1.2%	Shares	Sole	2024-10-22
2024-06-30	$307,812	2,106	—	Shares	Sole	2024-08-06
No filing history on record for this holder in this stock.